Literature DB >> 7104768

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

A Gjedde.   

Abstract

The 2-deoxyglucose (2-DG) method of functional neuroanatomical mapping25 was re-examined in order to (1) obtain physical descriptions of the transfer constants K1 and k2, (2) estimate the changes of the 'lumped constant' with the condition of the experimental animals, and (3) examine the use of 3-O-methylglucose (3-O-MG) to estimate the fraction of unphosphorylated 2-DG in the tissue, and the value of the 'lumped constant'. The transfer constants K1 and k2 were shown to be simple exponential forms of the apparent permeability of the cerebral capillary endothelium to glucose and glucose analogs. The 'lumped constant' was shown to be influenced by any reduction of the ratio between glucose transport and glucose phosphorylation in the tissue, e.g. by hypoglycemia and increased glycolysis, while hyperglycemia and decreased glycolysis resulted in very minor changes of the 'lumped constant'. The glucose analog 3-O-MG was shown accurately to trace unphosphorylated 2-DG in brain and to be an index of the brain content of glucose and the regional value of the 'lumped constant'. In addition, 3-O-MG proved to be an accurate tracer of unphosphorylated 2-DG for experimental times as low as 10 min.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104768     DOI: 10.1016/0165-0173(82)90018-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  74 in total

1.  Evaluation of iterative reconstruction (OSEM) versus filtered back-projection for the assessment of myocardial glucose uptake and myocardial perfusion using dynamic PET.

Authors:  Hanne M Søndergaard; Mette Marie Madsen; Karin Boisen; Morten Bøttcher; Ole Schmitz; Torsten T Nielsen; Hans Erik Bøtker; Søren B Hansen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10-11       Impact factor: 9.236

2.  Chronic ACE inhibitor treatment increases angiotensin type 1 receptor binding in vivo in the dog kidney.

Authors:  Tamas G Zober; Maria Elena Fabucci; Wei Zheng; Phillip R Brown; Esen Seckin; William B Mathews; Kathryn Sandberg; Zsolt Szabo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-08       Impact factor: 9.236

3.  Local cerebral glucose utilization in the Ammon's horn and dentate gyrus of the rat brain.

Authors:  A Wree; A Schleicher; K Zilles; T Beck
Journal:  Histochemistry       Date:  1988

4.  A kinetic solution for the paradoxical difference between F-Dopa and methionine.

Authors:  Masashi Kameyama; Yumi Umeda-Kameyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-12       Impact factor: 9.236

5.  Elevated dopamine D1 receptor availability in striatum of Göttingen minipigs after electroconvulsive therapy.

Authors:  Anne M Landau; Aage Ko Alstrup; Helene Audrain; Steen Jakobsen; Mette Simonsen; Arne Møller; Poul Videbech; Gregers Wegener; Albert Gjedde; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-16       Impact factor: 6.200

Review 6.  Dynamic whole-body PET imaging: principles, potentials and applications.

Authors:  Arman Rahmim; Martin A Lodge; Nicolas A Karakatsanis; Vladimir Y Panin; Yun Zhou; Alan McMillan; Steve Cho; Habib Zaidi; Michael E Casey; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-29       Impact factor: 9.236

7.  Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves.

Authors:  M Reimold; W Mueller-Schauenburg; G A Becker; G Reischl; B M Dohmen; R Bares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-19       Impact factor: 9.236

8.  Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain.

Authors:  Suresh Kumar Swaminathan; Kristen M Ahlschwede; Vidur Sarma; Geoffry L Curran; Rajesh S Omtri; Teresa Decklever; Val J Lowe; Joseph F Poduslo; Karunya K Kandimalla
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-01       Impact factor: 6.200

9.  Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.

Authors:  D F Wong; J C Harris; S Naidu; F Yokoi; S Marenco; R F Dannals; H T Ravert; M Yaster; A Evans; O Rousset; R N Bryan; A Gjedde; M J Kuhar; G R Breese
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 10.  Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology.

Authors:  Anthony F Shields
Journal:  Mol Imaging Biol       Date:  2006 May-Jun       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.